+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Vaccines Market by Type (Monovalent Vaccine, Multivalent Vaccine), Technology Type (Inactivated Vaccines, Live-Attenuated Vaccines, Messenger RNA (mRNA) Vaccines), Indication, Route of administration, Age Group - Forecast 2024-2030- Product Image
Global Vaccines Market by Type (Monovalent Vaccine, Multivalent Vaccine), Technology Type (Inactivated Vaccines, Live-Attenuated Vaccines, Messenger RNA (mRNA) Vaccines), Indication, Route of administration, Age Group - Forecast 2024-2030- Product Image
Sale

Global Vaccines Market by Type (Monovalent Vaccine, Multivalent Vaccine), Technology Type (Inactivated Vaccines, Live-Attenuated Vaccines, Messenger RNA (mRNA) Vaccines), Indication, Route of administration, Age Group - Forecast 2024-2030

  • PDF Icon

    Report

  • 190 Pages
  • May 2024
  • Region: Global
  • 360iResearch™
  • ID: 4985895
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Vaccines Market size was estimated at USD 55.66 billion in 2023, USD 59.94 billion in 2024, and is expected to grow at a CAGR of 7.79% to reach USD 94.14 billion by 2030.

Vaccines are biological preparations that equip the body's immune system with the capability to combat disease-causing microbes effectively. They work by stimulating the immune response to generate a specific defense mechanism, predominantly in the form of antibodies, against harmful pathogens. The rising incidence of infectious diseases globally and the rise in immunization programs worldwide significantly influence this growth. Moreover, favorable government initiatives and policies for vaccine development are also driving market growth.

High development costs, lengthy testing and approval process issues over product recalls, and inaccessibility in a few regions pose challenges to the growth of the vaccine market. Integration of adjuvants in vaccines, development of therapeutic vaccines, and growth in the contract manufacturing of the vaccines are expected to create significant growth opportunities in the market.

Regional Insights

In Asia-Pacific, robust economies such as China, India, and Japan have exhibited significant growth in vaccine markets due to large population densities and high prevalence of infectious diseases, necessitating comprehensive immunization drives. There's a high need for vaccines in the Americas, comprising countries such as the United States and Canada, owing to the demographic makeup and an expansive public health infrastructure. Significant investments in research and development (R&D) of vaccines, recent patents, and initiatives further fuel the growth. The EMEA region, with diverse economic landscapes, displays varying consumer behavior.

The European Union, with well-funded health systems, necessitates extensive immunization programs. The Middle East and Africa possess a significant potential for market growth. Initiatives such as the collaboration between the Serum Institute of India and the Africa Vaccine Acquisition Trust in 2022 to supply COVID-19 vaccines are pivotal changes reshaping this landscape.

Market Trends by Segment

  • Type: Significant preference for monovalent vaccines for specific disease prevention
  • Technology Type: Rising development in the conjugate vaccines as an viable alternative
  • Indication: Growing need for DPT vaccine for protection against serious respiratory ailments
  • Route of administration: Increasing adoption of oral vaccines for longer-lasting immune responses
  • Age Group: wider adoption of pediatric vaccine as a preventive measure owing to rising HPV vaccine usability

Industry Insights

  • Market Dynamics
  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis
  • FPNV Positioning Matrix
  • Market Share Analysis
  • Strategy Analysis and Recommendations

Recent Developments

Oxford R21/Matrix-M Malaria Vaccine Receives WHO Recommendation for Use

The R21/Matrix-M malaria vaccine, developed by the University of Oxford with the Serum Institute of India with Novavax's adjuvant technology, has received a recommendation for use by the World Health Organization (WHO) based on its adherence to safety, quality, and effectiveness standards. The vaccine has been licensed for use in Ghana, Nigeria, and Burkina Faso.

BioNTech and CEPI Announce Partnership to Advance mRNA Mpox Vaccine Development and Support CEPI’s 100 Days Mission

BioNTech SE and the Coalition for Epidemic Preparedness Innovations (CEPI) formed a strategic partnership to develop mRNA-based vaccine candidates, such as BNT166, with the goal of preventing the occurrence of Mpox. In support of their 100 Days Initiative Mission, CEPI has committed up to USD 90 million in funding to this project, which aims to safeguard against future pandemics. The BNT166 vaccine candidate is expected to serve as a safe and scalable prophylactic against Mpox, while also generating valuable data for the rapid development of vaccines targeting Orthopoxviruses. This partnership between BioNTech and CEPI is dedicated to ensuring equitable access to any licensed vaccines resulting from this initiative at an affordable price in lower-income countries.

Pfizer and BioNTech Receive U.S. FDA Approval for 2023-2024 COVID-19 Vaccine

Pfizer Inc. and BioNTech SE received the U.S. Food and Drug Administration (FDA) approval for emergency use authorization for their COVID-19 vaccine. This (COMIRNATY 2023-2024 Formulation) authorization includes individuals 12 years and older, with additional authorization for individuals 6 months to 11 years of age. The vaccine is recommended as a single dose for most individuals aged 5 years and older. This updated vaccine aims to provide improved protection against symptomatic and severe disease.

Key Company Profiles

The report delves into recent significant developments in the Vaccines Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Astellas Pharma Inc., AstraZeneca PLC, Bavarian Nordic A/S, Bharat Biotech Ltd., Biological E. Limited, Chongqing Zhifei Biological Products Co.,Ltd., CSL Limited, CureVac SE, Daiichi Sankyo Co., Ltd., Emergent BioSolutions Inc., Gennova Biopharmaceuticals Limited, GlaxoSmithKline PLC, Inovio Pharmaceuticals, Inc., Johnson & Johnson Services, Inc., Merck KGaA, Mitsubishi Chemical Group Corporation, Moderna Inc., Novavax, Inc., Pfizer Inc., Sanofi Group, Serum Institute of India Pvt. Ltd., Sinovac Biotech Ltd., Takeda Pharmaceutical Company Limited, and Zydus Lifesciences Limited.

This research report offers invaluable insights into various crucial aspects of the Vaccines Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising incidence of infectious diseases globally
5.1.1.2. Favorable government initiatives and policies for vaccine development
5.1.1.3. Growing focus on immunization across the world
5.1.2. Restraints
5.1.2.1. High development costs, lengthy testing and approval processes
5.1.3. Opportunities
5.1.3.1. Integration of adjuvants in vaccines and development of therapeutic vaccines
5.1.3.2. Growth in the contract manufacturing of the vaccines
5.1.4. Challenges
5.1.4.1. Issues over product recalls and inaccessibility in few regions
5.2. Market Segmentation Analysis
5.2.1. Type: Significant preference for monovalent vaccines for specific disease prevention
5.2.2. Technology Type: Rising development in the conjugate vaccines as an viable alternative
5.2.3. Indication: Growing need for DPT vaccine for protection against serious respiratory ailments
5.2.4. Route of administration: Increasing adoption of oral vaccines for longer-lasting immune responses
5.2.5. Age Group: wider adoption of pediatric vaccine as a preventive measure owing to rising HPV vaccine usability
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Vaccines Market, by Type
6.1. Introduction
6.2. Monovalent Vaccine
6.3. Multivalent Vaccine
7. Vaccines Market, by Technology Type
7.1. Introduction
7.2. Inactivated Vaccines
7.3. Live-Attenuated Vaccines
7.4. Messenger RNA (mRNA) Vaccines
7.5. Subunit, Recombinant, Polysaccharide, & Conjugate Vaccines
7.6. Toxoid Vaccines
7.7. Viral Vector Vaccines
8. Vaccines Market, by Indication
8.1. Introduction
8.2. DPT
8.3. Hepatitis
8.4. Human Papillomavirus
8.5. Influenza
8.6. Measles
8.7. Meningococcal Disease
8.8. Mumps & Rubella
8.9. Pneumococcal Disease
8.10. Polio
8.11. Rotavirus
8.12. Varicella
9. Vaccines Market, by Route of administration
9.1. Introduction
9.2. Intramuscular & Subcutaneous
9.3. Oral
10. Vaccines Market, by Age Group
10.1. Introduction
10.2. Adults
10.3. Pediatric
11. Americas Vaccines Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Vaccines Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Vaccines Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. Market Share Analysis, 2023
14.2. FPNV Positioning Matrix, 2023
14.3. Competitive Scenario Analysis
14.3.1. Oxford R21/Matrix-M Malaria Vaccine Receives WHO Recommendation for Use
14.3.2. BioNTech and CEPI Announce Partnership to Advance mRNA Mpox Vaccine Development and Support CEPI’s 100 Days Mission
14.3.3. Pfizer and BioNTech Receive U.S. FDA Approval for 2023-2024 COVID-19 Vaccine
14.4. Strategy Analysis & Recommendation
15. Competitive Portfolio
15.1. Key Company Profiles
15.2. Key Product Portfolio
List of Figures
FIGURE 1. VACCINES MARKET RESEARCH PROCESS
FIGURE 2. VACCINES MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL VACCINES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL VACCINES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. VACCINES MARKET DYNAMICS
FIGURE 7. GLOBAL VACCINES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. GLOBAL VACCINES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2023 VS 2030 (%)
FIGURE 10. GLOBAL VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL VACCINES MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 12. GLOBAL VACCINES MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
FIGURE 14. GLOBAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL VACCINES MARKET SIZE, BY AGE GROUP, 2023 VS 2030 (%)
FIGURE 16. GLOBAL VACCINES MARKET SIZE, BY AGE GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. AMERICAS VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES VACCINES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 20. UNITED STATES VACCINES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 25. VACCINES MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 26. VACCINES MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. VACCINES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL VACCINES MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL VACCINES MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL VACCINES MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL VACCINES MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL VACCINES MARKET SIZE, BY MONOVALENT VACCINE, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL VACCINES MARKET SIZE, BY MONOVALENT VACCINE, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL VACCINES MARKET SIZE, BY MULTIVALENT VACCINE, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL VACCINES MARKET SIZE, BY MULTIVALENT VACCINE, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL VACCINES MARKET SIZE, BY INACTIVATED VACCINES, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL VACCINES MARKET SIZE, BY INACTIVATED VACCINES, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL VACCINES MARKET SIZE, BY LIVE-ATTENUATED VACCINES, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL VACCINES MARKET SIZE, BY LIVE-ATTENUATED VACCINES, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL VACCINES MARKET SIZE, BY MESSENGER RNA (MRNA) VACCINES, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL VACCINES MARKET SIZE, BY MESSENGER RNA (MRNA) VACCINES, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL VACCINES MARKET SIZE, BY SUBUNIT, RECOMBINANT, POLYSACCHARIDE, & CONJUGATE VACCINES, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL VACCINES MARKET SIZE, BY SUBUNIT, RECOMBINANT, POLYSACCHARIDE, & CONJUGATE VACCINES, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL VACCINES MARKET SIZE, BY TOXOID VACCINES, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL VACCINES MARKET SIZE, BY TOXOID VACCINES, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL VACCINES MARKET SIZE, BY VIRAL VECTOR VACCINES, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL VACCINES MARKET SIZE, BY VIRAL VECTOR VACCINES, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL VACCINES MARKET SIZE, BY DPT, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL VACCINES MARKET SIZE, BY DPT, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL VACCINES MARKET SIZE, BY HEPATITIS, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL VACCINES MARKET SIZE, BY HEPATITIS, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL VACCINES MARKET SIZE, BY HUMAN PAPILLOMAVIRUS, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL VACCINES MARKET SIZE, BY HUMAN PAPILLOMAVIRUS, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL VACCINES MARKET SIZE, BY INFLUENZA, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL VACCINES MARKET SIZE, BY INFLUENZA, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL VACCINES MARKET SIZE, BY MEASLES, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL VACCINES MARKET SIZE, BY MEASLES, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL VACCINES MARKET SIZE, BY MENINGOCOCCAL DISEASE, BY REGION, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL VACCINES MARKET SIZE, BY MENINGOCOCCAL DISEASE, BY REGION, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL VACCINES MARKET SIZE, BY MUMPS & RUBELLA, BY REGION, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL VACCINES MARKET SIZE, BY MUMPS & RUBELLA, BY REGION, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL VACCINES MARKET SIZE, BY PNEUMOCOCCAL DISEASE, BY REGION, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL VACCINES MARKET SIZE, BY PNEUMOCOCCAL DISEASE, BY REGION, 2024-2030 (USD MILLION)
TABLE 45. GLOBAL VACCINES MARKET SIZE, BY POLIO, BY REGION, 2018-2023 (USD MILLION)
TABLE 46. GLOBAL VACCINES MARKET SIZE, BY POLIO, BY REGION, 2024-2030 (USD MILLION)
TABLE 47. GLOBAL VACCINES MARKET SIZE, BY ROTAVIRUS, BY REGION, 2018-2023 (USD MILLION)
TABLE 48. GLOBAL VACCINES MARKET SIZE, BY ROTAVIRUS, BY REGION, 2024-2030 (USD MILLION)
TABLE 49. GLOBAL VACCINES MARKET SIZE, BY VARICELLA, BY REGION, 2018-2023 (USD MILLION)
TABLE 50. GLOBAL VACCINES MARKET SIZE, BY VARICELLA, BY REGION, 2024-2030 (USD MILLION)
TABLE 51. GLOBAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 52. GLOBAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 53. GLOBAL VACCINES MARKET SIZE, BY INTRAMUSCULAR & SUBCUTANEOUS, BY REGION, 2018-2023 (USD MILLION)
TABLE 54. GLOBAL VACCINES MARKET SIZE, BY INTRAMUSCULAR & SUBCUTANEOUS, BY REGION, 2024-2030 (USD MILLION)
TABLE 55. GLOBAL VACCINES MARKET SIZE, BY ORAL, BY REGION, 2018-2023 (USD MILLION)
TABLE 56. GLOBAL VACCINES MARKET SIZE, BY ORAL, BY REGION, 2024-2030 (USD MILLION)
TABLE 57. GLOBAL VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 58. GLOBAL VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 59. GLOBAL VACCINES MARKET SIZE, BY ADULTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 60. GLOBAL VACCINES MARKET SIZE, BY ADULTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 61. GLOBAL VACCINES MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2023 (USD MILLION)
TABLE 62. GLOBAL VACCINES MARKET SIZE, BY PEDIATRIC, BY REGION, 2024-2030 (USD MILLION)
TABLE 63. AMERICAS VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 64. AMERICAS VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 65. AMERICAS VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2023 (USD MILLION)
TABLE 66. AMERICAS VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2024-2030 (USD MILLION)
TABLE 67. AMERICAS VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 68. AMERICAS VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 69. AMERICAS VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 70. AMERICAS VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 71. AMERICAS VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 72. AMERICAS VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 73. AMERICAS VACCINES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 74. AMERICAS VACCINES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 75. ARGENTINA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 76. ARGENTINA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 77. ARGENTINA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2023 (USD MILLION)
TABLE 78. ARGENTINA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2024-2030 (USD MILLION)
TABLE 79. ARGENTINA VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 80. ARGENTINA VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 81. ARGENTINA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 82. ARGENTINA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 83. ARGENTINA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 84. ARGENTINA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 85. BRAZIL VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 86. BRAZIL VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 87. BRAZIL VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2023 (USD MILLION)
TABLE 88. BRAZIL VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2024-2030 (USD MILLION)
TABLE 89. BRAZIL VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 90. BRAZIL VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 91. BRAZIL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 92. BRAZIL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 93. BRAZIL VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 94. BRAZIL VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 95. CANADA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 96. CANADA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 97. CANADA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2023 (USD MILLION)
TABLE 98. CANADA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2024-2030 (USD MILLION)
TABLE 99. CANADA VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 100. CANADA VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 101. CANADA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 102. CANADA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 103. CANADA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 104. CANADA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 105. MEXICO VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 106. MEXICO VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 107. MEXICO VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2023 (USD MILLION)
TABLE 108. MEXICO VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2024-2030 (USD MILLION)
TABLE 109. MEXICO VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 110. MEXICO VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 111. MEXICO VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 112. MEXICO VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 113. MEXICO VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 114. MEXICO VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 115. UNITED STATES VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 116. UNITED STATES VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 117. UNITED STATES VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2023 (USD MILLION)
TABLE 118. UNITED STATES VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2024-2030 (USD MILLION)
TABLE 119. UNITED STATES VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 120. UNITED STATES VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 121. UNITED STATES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 122. UNITED STATES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 123. UNITED STATES VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 124. UNITED STATES VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 125. UNITED STATES VACCINES MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 126. UNITED STATES VACCINES MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 127. ASIA-PACIFIC VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 128. ASIA-PACIFIC VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 129. ASIA-PACIFIC VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2023 (USD MILLION)
TABLE 130. ASIA-PACIFIC VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2024-2030 (USD MILLION)
TABLE 131. ASIA-PACIFIC VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 132. ASIA-PACIFIC VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 133. ASIA-PACIFIC VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 134. ASIA-PACIFIC VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 135. ASIA-PACIFIC VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 136. ASIA-PACIFIC VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 137. ASIA-PACIFIC VACCINES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 138. ASIA-PACIFIC VACCINES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 139. AUSTRALIA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 140. AUSTRALIA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 141. AUSTRALIA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2023 (USD MILLION)
TABLE 142. AUSTRALIA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2024-2030 (USD MILLION)
TABLE 143. AUSTRALIA VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 144. AUSTRALIA VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 145. AUSTRALIA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 146. AUSTRALIA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 147. AUSTRALIA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 148. AUSTRALIA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 149. CHINA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 150. CHINA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 151. CHINA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2023 (USD MILLION)
TABLE 152. CHINA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2024-2030 (USD MILLION)
TABLE 153. CHINA VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 154. CHINA VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 155. CHINA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 156. CHINA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 157. CHINA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 158. CHINA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 159. INDIA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 160. INDIA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 161. INDIA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2023 (USD MILLION)
TABLE 162. INDIA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2024-2030 (USD MILLION)
TABLE 163. INDIA VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 164. INDIA VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 165. INDIA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 166. INDIA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 167. INDIA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 168. INDIA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 169. INDONESIA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 170. INDONESIA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 171. INDONESIA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2023 (USD MILLION)
TABLE 172. INDONESIA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2024-2030 (USD MILLION)
TABLE 173. INDONESIA VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 174. INDONESIA VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 175. INDONESIA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 176. INDONESIA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 177. INDONESIA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 178. INDONESIA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 179. JAPAN VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 180. JAPAN VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 181. JAPAN VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2023 (USD MILLION)
TABLE 182. JAPAN VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2024-2030 (USD MILLION)
TABLE 183. JAPAN VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 184. JAPAN VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 185. JAPAN VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 186. JAPAN VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 187. JAPAN VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 188. JAPAN VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 189. MALAYSIA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 190. MALAYSIA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 191. MALAYSIA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2023 (USD MILLION)
TABLE 192. MALAYSIA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2024-2030 (USD MILLION)
TABLE 193. MALAYSIA VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 194. MALAYSIA VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 195. MALAYSIA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 196. MALAYSIA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 197. MALAYSIA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 198. MALAYSIA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 199. PHILIPPINES VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 200. PHILIPPINES VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 201. PHILIPPINES VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2023 (USD MILLION)
TABLE 202. PHILIPPINES VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2024-2030 (USD MILLION)
TABLE 203. PHILIPPINES VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 204. PHILIPPINES VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 205. PHILIPPINES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 206. PHILIPPINES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 207. PHILIPPINES VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 208. PHILIPPINES VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 209. SINGAPORE VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 210. SINGAPORE VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 211. SINGAPORE VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2023 (USD MILLION)
TABLE 212. SINGAPORE VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2024-2030 (USD MILLION)
TABLE 213. SINGAPORE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 214. SINGAPORE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 215. SINGAPORE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 216. SINGAPORE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 217. SINGAPORE VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 218. SINGAPORE VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 219. SOUTH KOREA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 220. SOUTH KOREA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 221. SOUTH KOREA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2023 (USD MILLION)
TABLE 222. SOUTH KOREA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2024-2030 (USD MILLION)
TABLE 223. SOUTH KOREA VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 224. SOUTH KOREA VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 225. SOUTH KOREA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 226. SOUTH KOREA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 227. SOUTH KOREA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 228. SOUTH KOREA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 229. TAIWAN VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 230. TAIWAN VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 231. TAIWAN VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2023 (USD MILLION)
TABLE 232. TAIWAN VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2024-2030 (USD MILLION)
TABLE 233. TAIWAN VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 234. TAIWAN VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 235. TAIWAN VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 236. TAIWAN VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 237. TAIWAN VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 238. TAIWAN VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 239. THAILAND VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 240. THAILAND VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 241. THAILAND VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2023 (USD MILLION)
TABLE 242. THAILAND VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2024-2030 (USD MILLION)
TABLE 243. THAILAND VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 244. THAILAND VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 245. THAILAND VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 246. THAILAND VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 247. THAILAND VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 248. THAILAND VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 249. VIETNAM VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 250. VIETNAM VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 251. VIETNAM VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2023 (USD MILLION)
TABLE 252. VIETNAM VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2024-2030 (USD MILLION)
TABLE 253. VIETNAM VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 254. VIETNAM VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 255. VIETNAM VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 256. VIETNAM VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 257. VIETNAM VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 258. VIETNAM VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 259. EUROPE, MIDDLE EAST & AFRICA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2023 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2024-2030 (USD MILLION)
TABLE 263. EUROPE, MIDDLE EAST & AFRICA VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 264. EUROPE, MIDDLE EAST & AFRICA VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 265. EUROPE, MIDDLE EAST & AFRICA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 266. EUROPE, MIDDLE EAST & AFRICA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 267. EUROPE, MIDDLE EAST & AFRICA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 268. EUROPE, MIDDLE EAST & AFRICA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 269. EUROPE, MIDDLE EAST & AFRICA VACCINES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 270. EUROPE, MIDDLE EAST & AFRICA VACCINES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 271. DENMARK VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 272. DENMARK VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 273. DENMARK VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2023 (USD MILLION)
TABLE 274. DENMARK VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2024-2030 (USD MILLION)
TABLE 275. DENMARK VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 276. DENMARK VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 277. DENMARK VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 278. DENMARK VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 279. DENMARK VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 280. DENMARK VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 281. EGYPT VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 282. EGYPT VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 283. EGYPT VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2023 (USD MILLION)
TABLE 284. EGYPT VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2024-2030 (USD MILLION)
TABLE 285. EGYPT VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 286. EGYPT VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 287. EGYPT VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 288. EGYPT VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 289. EGYPT VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 290. EGYPT VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 291. FINLAND VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 292. FINLAND VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 293. FINLAND VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2023 (USD MILLION)
TABLE 294. FINLAND VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2024-2030 (USD MILLION)
TABLE 295. FINLAND VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 296. FINLAND VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 297. FINLAND VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 298. FINLAND VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 299. FINLAND VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 300. FINLAND VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 301. FRANCE VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 302. FRANCE VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 303. FRANCE VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2023 (USD MILLION)
TABLE 304. FRANCE VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2024-2030 (USD MILLION)
TABLE 305. FRANCE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 306. FRANCE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 307. FRANCE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 308. FRANCE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 309. FRANCE VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 310. FRANCE VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 311. GERMANY VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 312. GERMANY VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 313. GERMANY VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2023 (USD MILLION)
TABLE 314. GERMANY VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2024-2030 (USD MILLION)
TABLE 315. GERMANY VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 316. GERMANY VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 317. GERMANY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 318. GERMANY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 319. GERMANY VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 320. GERMANY VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 321. ISRAEL VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 322. ISRAEL VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 323. ISRAEL VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2023 (USD MILLION)
TABLE 324. ISRAEL VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2024-2030 (USD MILLION)
TABLE 325. ISRAEL VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 326. ISRAEL VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 327. ISRAEL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 328. ISRAEL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 329. ISRAEL VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 330. ISRAEL VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 331. ITALY VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 332. ITALY VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 333. ITALY VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2023 (USD MILLION)
TABLE 334. ITALY VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2024-2030 (USD MILLION)
TABLE 335. ITALY VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 336. ITALY VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 337. ITALY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 338. ITALY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 339. ITALY VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 340. ITALY VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 341. NETHERLANDS VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 342. NETHERLANDS VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 343. NETHERLANDS VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2023 (USD MILLION)
TABLE 344. NETHERLANDS VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2024-2030 (USD MILLION)
TABLE 345. NETHERLANDS VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 346. NETHERLANDS VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 347. NETHERLANDS VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 348. NETHERLANDS VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 349. NETHERLANDS VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 350. NETHERLANDS VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 351. NIGERIA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 352. NIGERIA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 353. NIGERIA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2023 (USD MILLION)
TABLE 354. NIGERIA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2024-2030 (USD MILLION)
TABLE 355. NIGERIA VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 356. NIGERIA VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 357. NIGERIA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 358. NIGERIA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 359. NIGERIA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 360. NIGERIA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 361. NORWAY VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 362. NORWAY VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 363. NORWAY VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2023 (USD MILLION)
TABLE 364. NORWAY VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2024-2030 (USD MILLION)
TABLE 365. NORWAY VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 366. NORWAY VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 367. NORWAY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 368. NORWAY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 369. NORWAY VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 370. NORWAY VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 371. POLAND VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 372. POLAND VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 373. POLAND VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2023 (USD MILLION)
TABLE 374. POLAND VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2024-2030 (USD MILLION)
TABLE 375. POLAND VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 376. POLAND VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 377. POLAND VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 378. POLAND VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 379. POLAND VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 380. POLAND VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 381. QATAR VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 382. QATAR VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 383. QATAR VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2023 (USD MILLION)
TABLE 384. QATAR VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2024-2030 (USD MILLION)
TABLE 385. QATAR VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 386. QATAR VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 387. QATAR VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 388. QATAR VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 389. QATAR VACCINES MARKET SIZE, BY AGE GROUP, 2018-202

Companies Mentioned

  • Abbott Laboratories
  • Astellas Pharma Inc.
  • AstraZeneca PLC
  • Bavarian Nordic A/S
  • Bharat Biotech Ltd.
  • Biological E. Limited
  • Chongqing Zhifei Biological Products Co.,Ltd.
  • CSL Limited
  • CureVac SE
  • Daiichi Sankyo Co., Ltd.
  • Emergent BioSolutions Inc.
  • Gennova Biopharmaceuticals Limited
  • GlaxoSmithKline PLC
  • Inovio Pharmaceuticals, Inc.
  • Johnson & Johnson Services, Inc.
  • Merck KGaA
  • Mitsubishi Chemical Group Corporation
  • Moderna Inc.
  • Novavax, Inc.
  • Pfizer Inc.
  • Sanofi Group
  • Serum Institute of India Pvt. Ltd.
  • Sinovac Biotech Ltd.
  • Takeda Pharmaceutical Company Limited
  • Zydus Lifesciences Limited

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages190
PublishedMay 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 59.94 Billion
Forecasted Market Value ( USD ) by 2030 $ 94.14 Billion
Compound Annual Growth Rate7.7%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Global Aquaculture Vaccines Market by Type (DNA Vaccines, Inactivated Vaccines, Live Attenuated Vaccines), Product (DNA Vaccines, Inactivated Vaccines), Route of Administration, Application, End-User - Forecast 2024-2030 - Product Image

Global Aquaculture Vaccines Market by Type (DNA Vaccines, Inactivated Vaccines, Live Attenuated Vaccines), Product (DNA Vaccines, Inactivated Vaccines), Route of Administration, Application, End-User - Forecast 2024-2030

  • Report
  • 182 Pages
  • Global
From
Global Shingles Vaccine Market by Product (SkyZoster, Zostavax, ??Shingrix), Type (Live Attenuated Vaccine, Recombinant Vaccine) - Forecast 2024-2030 - Product Image

Global Shingles Vaccine Market by Product (SkyZoster, Zostavax, ??Shingrix), Type (Live Attenuated Vaccine, Recombinant Vaccine) - Forecast 2024-2030

  • Report
  • 180 Pages
  • Global
From
RNA Therapeutics Market and RNA Vaccines Market by Type of Modality, Type of Molecule, Therapeutic Areas, Route of Administration, Key Geographical Regions (North America, Europe and Asia-Pacific) and Leading Players: Industry Trends and Global Forecasts, 2023-2035 - Product Image

RNA Therapeutics Market and RNA Vaccines Market by Type of Modality, Type of Molecule, Therapeutic Areas, Route of Administration, Key Geographical Regions (North America, Europe and Asia-Pacific) and Leading Players: Industry Trends and Global Forecasts, 2023-2035

  • Report
  • 170 Pages
  • Global
From
mRNA Vaccines and Therapeutics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2021 - 2029 - Product Image

mRNA Vaccines and Therapeutics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2021 - 2029

  • Report
  • 159 Pages
  • Global
From
mRNA Vaccines Market Report 2023-2033 - Product Image

mRNA Vaccines Market Report 2023-2033

  • Report
  • 215 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.